India pharma sales jump 12.1% led by Sun, Zydus

In 2026, the medicine business in India is growing again after a few slow years.

In July, people bought about 12% more medicines than they did a year before.

A big reason is that some medicines got more expensive, and companies launched new medicines.

Another big reason is that medicines for diabetes are selling very fast.

These medicines are called GLP-1 drugs, and they are also used for weight loss.

Two companies, Zydus and Sun Pharma, grew faster than most others.

Almost every medicine company grew more than the whole market.

Only one company, called IPCA, grew slower because some of its medicines did not sell well.

Experts at the company Nomura say big medicine companies will keep growing by launching new products.